by Sara M. Nolte | Sep 21, 2022
We (or maybe it’s just me) talk about cancer immunotherapy around here A LOT. It’s hard not to when there are so many new advancements in this field of cancer research! I thought it was time to provide a guide to cancer immunotherapy, highlighting some of the more...
by Cal Strode | Sep 15, 2022
OmniaBio Inc., a subsidiary of CCRM, is building the largest facility of its kind in Canada, providing specialized manufacturing to the flourishing cell and gene therapy (CGT) industry. The new contract development and manufacturing organization (CDMO) will focus on...
by Cal Strode | Aug 17, 2022
Launched in June of 2015, ExCellThera is a clinical-stage biotechnology company making strides in developing robust and cost-effective processes for growing blood stem cells for therapeutic use, backed by award-winning proprietary technology. The company was founded...
by CCRM Australia | Aug 1, 2022
This post is by Harmanpreet Harmanpreet, who interned with CCRM Australia. The CCRM Australia Training Program seeks to facilitate training for the future workforce of the Australian regenerative medicine sector and includes an internship program that accepts...
by Stacey Johnson | Jul 22, 2022
The PR team at the Emily Whitehead Foundation, established in 2015, has been busy of late. The month of June saw the premiere of Of Medicine and Miracles, a documentary about Emily Whitehead and directed by Academy Award winning filmmaker Ross Kauffman, which played...
by Lyla El-Fayomi | Jul 7, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I sample the latest and greatest findings in recent press and package them into a single post. In this double issue, I cover a gene therapy for...
Comments